PATENT CLAIM ANALYSIS

Application Number: 16250733
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-07
Patent Classification: ["424", "009300"]

Abstract:
The present invention relates, in part, to isolated antibodies that specifically interact with and show measurable binding affinity to an epitope of the tau protein. Such antibodies may be used for the modulation of tau activity and/or aggregation, to study the effects of the tau protein on cell function and, in certain embodiments, for the treatment and/or prevention of a disease or condition associated with neurodegenerative tauopathy.

Claim (Index 63):
A method for in vivo detection of or targeting a therapeutic or diagnostic agent to tau in the human or animal body, comprising administering a composition comprising the antibody, or fragment thereof, of  claim 49  attached to a therapeutic or diagnostic agent.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 99.0
- Lexical Diversity: 1.45098
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15552633', '15552614', '15528333', '15342629', '14154954']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6845226359215918
- 35 USC 102 Novelty (BERT): 0.6542919193124929
- Combined Prediction Score: 0.6814995642606819
- Mean Citation Score: 442.0793660000001
- Max Citation Score: 674.6227
- Similarity Product: 579.3553148854733

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test